Death Due to Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report
- PMID: 37424979
- PMCID: PMC10324870
- DOI: 10.36518/2689-0216.1499
Death Due to Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report
Abstract
Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a life-threatening, multi-organ adverse drug reaction with an incidence of 1 in 1000 to 1 in 10 000 high-risk drug exposures.
Case presentation: An elderly female presented to the hospital with progressive weakness and a diffuse erythematous macular rash covering most of her body that started 3 days prior. Over the next 3 days, the patient quickly deteriorated, developing disorientation with acute onset left-sided weakness, leukocytosis, thrombocytopenia, eosinophilia, liver and kidney failure, and hypoxia. Clinical and histological changes supported the diagnosis of DRESS syndrome caused by intravenous (IV) ampicillin administered during a prior hospitalization for a urinary tract infection. Systemic corticosteroids were initiated quickly thereafter, but the patient ultimately succumbed to complications caused by DRESS syndrome.
Conclusion: There are currently no randomized trials evaluating treatments for DRESS, and evidenced-based guidelines are lacking. Viral reactivation has also been suggested as a possible complication of DRESS syndrome, though the true incidence and association remain unclear. Although we started our patient on high-dose IV corticosteroids early in her course, she still succumbed to complications of DRESS syndrome. Further research into the treatment of DRESS syndrome and its association with viral reactivation is essential.
Keywords: DRESS syndrome; ampicillin; drug hypersensitivity syndrome; drug reaction; intravenous ampicillin; severe cutaneous adverse reaction.
© 2023 HCA Physician Services, Inc. d/b/a Emerald Medical Education.
Conflict of interest statement
Conflicts of Interest The authors declare that they have no conflicts of interest.
Figures



Similar articles
-
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.Pan Afr Med J. 2017 Nov 9;28:218. doi: 10.11604/pamj.2017.28.218.10828. eCollection 2017. Pan Afr Med J. 2017. PMID: 29629004 Free PMC article.
-
Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.Eur J Paediatr Neurol. 2016 Nov;20(6):957-961. doi: 10.1016/j.ejpn.2016.07.023. Epub 2016 Aug 1. Eur J Paediatr Neurol. 2016. PMID: 27524391
-
Drug Reaction With Eosinophilia and Systemic Symptoms-Associated Perimyocarditis After Initiation of Anti-tuberculosis Therapy: A Case Report.Cureus. 2023 Apr 10;15(4):e37399. doi: 10.7759/cureus.37399. eCollection 2023 Apr. Cureus. 2023. PMID: 37181989 Free PMC article.
-
DRESS syndrome: quetiapine associated case report and literature review.Int Clin Psychopharmacol. 2023 Sep 1;38(5):356-360. doi: 10.1097/YIC.0000000000000474. Epub 2023 May 8. Int Clin Psychopharmacol. 2023. PMID: 37159165 Review.
-
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections.Iran J Allergy Asthma Immunol. 2024 May 27;23(3):339-346. doi: 10.18502/ijaai.v23i3.15643. Iran J Allergy Asthma Immunol. 2024. PMID: 39422393 Review.
Cited by
-
Vancomycin-Induced DRESS Syndrome: A Systematic Review of Case Reports.Hosp Pharm. 2025 May 23:00185787251341739. doi: 10.1177/00185787251341739. Online ahead of print. Hosp Pharm. 2025. PMID: 40417636 Free PMC article. Review.
-
DRESS syndrome: an interaction between drugs, latent viruses, and the immune system.An Bras Dermatol. 2025 Jan-Feb;100(1):104-120. doi: 10.1016/j.abd.2023.12.010. Epub 2024 Nov 8. An Bras Dermatol. 2025. PMID: 39521708 Free PMC article. Review.
References
-
- Chen YH, Hsu SN, Shih YL, Hsieh TY. A fatal case of drug reaction with eosinophilia and systemic symptom syndrome associated with cytomegalovirus reactivation. J Med Sci. 2017;37(3):113–116. doi: 10.4103/jmedsci.jmedsci_61_16. - DOI
Publication types
LinkOut - more resources
Full Text Sources